Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Cerevel Therapeutics Hldg Inc WT (CEREW)

Cerevel Therapeutics Hldg Inc WT (CEREW)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Help
Go To:
Cerevel Therapeutics to Report Third Quarter 2021 Financial Results on Wednesday, November 10, 2021 Globe Newswire - Wed Oct 20, 2021

CAMBRIDGE, Mass., Oct. 20, 2021 (GLOBE NEWSWIRE) -- Cerevel Therapeutics (Nasdaq: CERE), a company dedicated to unraveling the mysteries of the brain...

CEREW : 18.07 (-3.27%)
CERE : 42.55 (-0.09%)
Cerevel Therapeutics Hosts Virtual R&D Event to Review CVL-871 in Dementia-Related Apathy and Provide Update on CVL-231 for the Treatment of Schizophrenia Globe Newswire - Thu Oct 7, 2021

Live webcast today from 10:00 to 11:30 a.m. ET CAMBRIDGE, Mass., Oct. 07, 2021 (GLOBE NEWSWIRE) -- Cerevel Therapeutics (Nasdaq: CERE), a company...

CERE : 42.55 (-0.09%)
CEREW : 18.07 (-3.27%)
Cerevel Therapeutics Announces Departure of CFO Kathy Yi Globe NewsWire - Tue Sep 21, 2021

Current Chief Accounting Officer Mark Bodenrader named as interim CFO

CEREW : 18.07 (-3.27%)
CERE : 42.55 (-0.09%)
Cerevel Therapeutics to Host Virtual R&D Event on October 7 Globe NewsWire - Fri Sep 10, 2021

Event will focus on CVL-871, a D1/D5 partial agonist in development for dementia-related apathy, and will include an update on CVL-231, an M4 positive allosteric modulator for the treatment of schizophrenia...

CEREW : 18.07 (-3.27%)
CERE : 42.55 (-0.09%)
Cerevel Therapeutics to Present at Upcoming Virtual Investor Conferences Globe NewsWire - Wed Sep 1, 2021

CAMBRIDGE, Mass., Sept. 01, 2021 (GLOBE NEWSWIRE) -- Cerevel Therapeutics (Nasdaq: CERE), a company dedicated to unraveling the mysteries of the brain to treat neuroscience diseases, announced that...

CEREW : 18.07 (-3.27%)
CERE : 42.55 (-0.09%)
Cerevel Therapeutics Reports Second Quarter 2021 Financial Results and Business Updates Globe NewsWire - Wed Aug 11, 2021

Announced positive topline results for CVL-231 in Phase 1b trial in schizophrenia

CEREW : 18.07 (-3.27%)
CERE : 42.55 (-0.09%)
Cerevel Therapeutics Announces Redemption of Public Warrants Globe NewsWire - Fri Jul 30, 2021

CAMBRIDGE, Mass., July 30, 2021 (GLOBE NEWSWIRE) -- Cerevel Therapeutics (Nasdaq: CERE; CEREW) (the “Company”), a company dedicated to unraveling the mysteries of the brain to treat neuroscience...

CERE : 42.55 (-0.09%)
CEREW : 18.07 (-3.27%)
Cerevel Therapeutics to Report Second Quarter 2021 Financial Results on Wednesday, August 11, 2021 Globe NewsWire - Thu Jul 22, 2021

CAMBRIDGE, Mass., July 22, 2021 (GLOBE NEWSWIRE) -- Cerevel Therapeutics (Nasdaq: CERE), a company dedicated to unraveling the mysteries of the brain to treat neuroscience diseases, today announced...

CEREW : 18.07 (-3.27%)
CERE : 42.55 (-0.09%)
Cerevel Therapeutics Announces Pricing of $350 Million Public Offering of Common Stock Globe NewsWire - Thu Jul 1, 2021

CAMBRIDGE, Mass., July 01, 2021 (GLOBE NEWSWIRE) -- Cerevel Therapeutics (Nasdaq: CERE), a company dedicated to unraveling the mysteries of the brain to treat neuroscience diseases, announced today the...

CEREW : 18.07 (-3.27%)
CERE : 42.55 (-0.09%)
Cerevel Therapeutics Announces Proposed Public Offering of Common Stock Globe NewsWire - Tue Jun 29, 2021

CAMBRIDGE, Mass., June 29, 2021 (GLOBE NEWSWIRE) -- Cerevel Therapeutics (Nasdaq: CERE), a company dedicated to unraveling the mysteries of the brain to treat neuroscience diseases, announced today that...

CEREW : 18.07 (-3.27%)
CERE : 42.55 (-0.09%)

Barchart Exclusives

2 Small-Cap Stocks With 40% to 60% Upside Barchart - Sat May 4, 2:45PM CDT
Wall Street believes these two growth stocks will soar, driven by the demand for their products. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot